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Letter to the Editor:
Hepatic Penetration ofa Single Large Duodenal Ulcer
(Accepted 25th July 2005)
Sir,
Wepresentararecaseoferosionofaduodenalulcer
into the liver in a gentleman with few risk factors
for peptic ulcer disease (PUD) and on long term
protium pump inhibitor (PPI).
PRESENTATION AND MANAGEMENT
An85yearoldmale,whohadbeenonomeprazolefor
18months,wasadmittedwithsubacutesmallbowel
obstruction of2 weeks duration. His past medical
history was Type 2 diabetes mellitus and warfarin
for atrial fibrillation. Prior to commencement of
omeprazole, he had been investigated for weight
loss with positive faecal occult blood test positive,
an oesophago-gastro-duodenoscopy (OGD) which
revealedaverymildstreakygastritisandnegativeH.
pyloritest,andacompletecolonoscopythatshowed
three histologically confirmed metaplastic polyps.
He had no history ofPUD, was not on NSAID's or
steroids, smokedabout 15cigarettes/dayanddrank
alcohol occasionally.
He subsequently developed acute small bowel
obstructionnecessitating anemergencylaparotomy
andwasfoundtohaveanobstructingcaecaltumour;
arighthemicolectomyandileocolicanastomosiswas
performed.Histologyconfirmedanadenocarcinoma.
On post operative day fifteen he started passing
moderate amounts of melena; there were no
features suggestive of an acute abdomen. He was
still haemodynamically stable and liver function
tests essentially normal though haemoglobin had
dropped from IOg/dl to 8g/dl bythe nextday when
he had an OGD. A deep copiously bleeding ulcer
approximately 2cm in diameter was found on the
anterior wall ofthe first part ofthe duodenum.
A laparotomy was performed after unsuccessful
attempts atinjectionwithadrenaline.Theulcerwas
then foundto have deeply eroded into theposterior
surface ofthe medial inferior segment ofthe liver.
This bleeding defect was adequately controlled by
figure-of-eightliverstitchesbuthesuddenlybecame
hypotensive from a myocardial infarct, failed to
respond to resuscitative measures and died intra-
operatively.
DISCUSSION
Mostperforations ofaduodenal ulcerinto the liver
are 'silent'withabsentorminimal abdominalpain.'
Diagnosis may be by histological examination of
endoscopic biopsies2 but most only become only
obvious at laparotomy or autopsy.3
PPIsarethemosteffectivedrugsforthesuppression
of gastric acid production;4 in duodenal ulcers,
omeprazole 20mg daily produced healing rates of
90 - 100% after4weeks.5 PPIs are also efficacious
in prevention ofbleeding from stress ulcers.6
Possibilities in this unusual case are that the ulcer
wasmissedduringtheinitialOGD,thathedeveloped
a fresh ulcerdespite PPIs, orthatthis was a case of
a single large penetrating stress ulcer. Since in any
case PPIsweremeantto be effective, this mayhave
beencase ofresistanceto omeprazole. Claessens et
al identified previous use ofPPIs, heavy smoking
and age over 60 years as factors consistently
associated with non response to PPIs.7 This patient
had all three.
CONCLUSION
Resistance to PPIs isuncommon7 butmay occurin
the elderly smoker post major surgery, leading to
potentially serious complications.
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